Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-24T07:54:41.106Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment of atrial septal defects in symptomatic children aged less than 2 years of age using the Amplatzer septal occluder

Published online by Cambridge University Press:  19 August 2008

Michael Vogel ,
Felix Berger ,
Ingo Dähnert ,
Peter Ewert  and
Peter E. Lange
Michael Vogel
Affiliation:
Grown Up Congenital Heart Department, Middlesex HospitalLondon, UK
Felix Berger
Affiliation:
Department of Congenital Heart Disease, Deutsches Herzzentrum Berlin, Berlin, Germany
Ingo Dähnert
Affiliation:
Department of Congenital Heart Disease, Deutsches Herzzentrum Berlin, Berlin, Germany
Peter Ewert
Affiliation:
Department of Congenital Heart Disease, Deutsches Herzzentrum Berlin, Berlin, Germany
Peter E. Lange
Affiliation:
Department of Congenital Heart Disease, Deutsches Herzzentrum Berlin, Berlin, Germany
Get access Rights & Permissions [Opens in a new window]

Abstract

Aims

To assess results of closure of atrial septal defects within the oval fossa by devices delivered by catheterisation in symptomatic infants and children under 2 years of age.

Methods and results

The Amplatzer septal occluder was used. Results, and complications of transcatheter device treatment in patients aged below 2 years were compared to previous results from our institution.

Patients

We attempted closure in 12 consecutive patients below the age of 2 years who presented with an atrial septal defect between May 1997 and 1999. Symptoms were failure to thrive in 6, frequent chest infections in 5, and the need for treatment of heart failure in the other. All were thought to have a defect suitable for interventional closure. The atrial defects were seen in isolation in 10 children, but 2 had associated pulmonary stenosis which had been treated by balloon dilation prior to placement of the Amplatzer occluder.

Results

The Amplatzer septal occluder was implanted at a mean age of 1.4 ± 0.4, with a range from 0.8 to 1.8 years. Ratios of pulmonaryto-systemic flow had been 2.1 ± 0.5, with a range from 1.6 and 3.2, and the defect was measured at 12 ± 4 mms. Fluoroscopy time was 12.8 ± 10.2 minutes, with a range from 5 to 43 minutes, and the time of the overall procedure was 162 ± 70 minutes, with a range from 85 to 360 minutes. It proved necessary to remove the device in 2 patients (16%) because of a residual shunt and movement after release. One of these developed transient neurological complications. Both subsequently underwent surgical treatment.

Conclusion

Symptomatic patients less than 2 years of age can undergo successful closure of an atrial septal defect using the Amplatzer device, but the rates of success are less, and procedure time longer, than in older children or adults.

Type
Original Article
Information
Cardiology in the Young , Volume 10 , Issue 5 , September 2000 , pp. 534 - 537
Copyright
Copyright © Cambridge University Press 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Phillips, SJOkies, JE, Henken, D,Sutherland, CO,Star, A. Complex of decundum atrial septal defect and congestive heart failure in infants.J Thorac Cardiovasc Surg 1975 70 690–700CrossRefGoogle ScholarPubMed
Hunt, CE, Lucas, RV jrSymptomatic atrial septal defect in infancy Circulation 1973 47: 1042–1048CrossRefGoogle ScholarPubMed
Dimich, I,Steinfeld, L, Park, SC. Symptomatic atrial septal defect in infants. Am Heart J 1973 85:601–604CrossRefGoogle ScholarPubMed
Bull, C,Deanfield, J,de Leval, M, Taylor, JFN,MaCartney, FJ. Correction of isolated secundum atrial septal defect in infancy.Arch Dis Child 1981 56: 784–786CrossRefGoogle ScholarPubMed
Spangler, JG,Feldt, RH,Danielson, GK. Secundum atrial sept aldefect encountered in infancy.J Thorac Cardiovasc Surg 1976 71:398–401CrossRefGoogle Scholar
Rao, PS, Langhough, R, Beekmann, RH, Lloyd, TR,Sideris, EB. Echocardiographic estimation of balloon-strechted diameter of secundum atrial septal defects from transcatheter occlusion. Am Heart J 1992 124: 172–175CrossRefGoogle ScholarPubMed
Berger, F, Ewert, FJStiller, B, Dahnert, I,Krings, G, Vogel, M, Lange PE. Intiale klinische Erfahrungen mit dem Amplatzer septal occluder ein selbstzentrierendes Doppelschirmchen zum Verschluβ des Vorhofseptumdefekts. Z Kardiol 1998; 87: 185–190Google Scholar
Berger, F, Ewert, P, Bjørnstad, PG, et al. Transcatheter closure as standard treatment for most intraatrial defects: experience in 200 patients treated with the Amplatzer septal occluder. Cardiol Young 1999 9: 468–473CrossRefGoogle Scholar
Berger, F, Vogel, M, Alexi-Meskishvili, V,Lange, PE. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg 1999 188: 674–678CrossRefGoogle Scholar
Rome, JJKeane, JFPerry, SBSpevak, PJ,Lock, JE. Doubleumbrella closure of atrial defects: initial clinical applications. Circulation 1990 82: 751–758CrossRefGoogle ScholarPubMed
Agarwal, SK, Ghosh, PK, Mittal, PK. Failure of devices used for closure of atrial septal defects: mechanisms and managment.J Thorac Cardiovasc Surg 1996 112: 21–26CrossRefGoogle Scholar
Rigby, M. The era of transcatheter closure of atrial septal defects. Heart 1999 81: 227–228CrossRefGoogle ScholarPubMed
Thanopoulos, BD, Laskari, CYTsaousis, GS, Zarayelan, A, Vekiou, A, Papadopoulos, GS. Closure of atrial septal defects with the Amplatzer occlusion device: preliminary results. J Am Coll Cardiol 1998 31: 1110–1116CrossRefGoogle ScholarPubMed
Ewert, P, Dähnert, I,Berger, F, Kästner, A, Vogel, M, Lange, PE. Feasibility and safety of transcatheter closure of atrial septal defects under echocardiographic guidance without fluoroscopy. Cardiol Young 1999 9: 136–140CrossRefGoogle Scholar